126 related articles for article (PubMed ID: 10634155)
1. No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation.
Macdonald GA; Tarish J; Whitehall VJ; McCann SJ; Mellick GD; Buttenshaw RL; Johnson AG; Young J; Leggett BA
J Gastroenterol Hepatol; 1999 Dec; 14(12):1188-91. PubMed ID: 10634155
[TBL] [Abstract][Full Text] [Related]
2. Heterozygosity for the Cys282Tyr mutation in the HFE gene and the risk of colorectal cancer (Netherlands).
van der A DL; van der Hel O; Roest M; van der Schouw YT; van Gils CH; Marx JJ; van Noord PA; Peeters PH
Cancer Causes Control; 2003 Aug; 14(6):541-5. PubMed ID: 12948285
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls.
Sánchez M; Bruguera M; Bosch J; Rodés J; Ballesta F; Oliva R
J Hepatol; 1998 Nov; 29(5):725-8. PubMed ID: 9833909
[TBL] [Abstract][Full Text] [Related]
4. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis.
Datz C; Lalloz MR; Vogel W; Graziadei I; Hackl F; Vautier G; Layton DM; Maier-Dobersberger T; Ferenci P; Penner E; Sandhofer F; Bomford A; Paulweber B
J Hepatol; 1997 Nov; 27(5):773-9. PubMed ID: 9382962
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.
Roberts AG; Whatley SD; Morgan RR; Worwood M; Elder GH
Lancet; 1997 Feb; 349(9048):321-3. PubMed ID: 9024376
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis.
Burt MJ; Upton JD; Morison IM; Chapman BA; Faed JM; George PM
N Z Med J; 1997 Nov; 110(1056):429-32. PubMed ID: 9418837
[TBL] [Abstract][Full Text] [Related]
7. Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany.
Meier P; Schuff-Werner P; Steiner M
Clin Lab; 2005; 51(9-10):539-43. PubMed ID: 16285477
[TBL] [Abstract][Full Text] [Related]
8. Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders.
Beckman LE; Van Landeghem GF; Sikström C; Wahlin A; Markevärn B; Hallmans G; Lenner P; Athlin L; Stenling R; Beckman L
Carcinogenesis; 1999 Jul; 20(7):1231-3. PubMed ID: 10383894
[TBL] [Abstract][Full Text] [Related]
9. Haemochromatosis: automated detection of the two point mutations in the HFE gene: Cys282Tyr and His63Asp.
Klingler KR; Zech D; Wielckens K
Clin Chem Lab Med; 2000 Dec; 38(12):1225-30. PubMed ID: 11205685
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland.
Tuomainen TP; Kontula K; Nyyssönen K; Lakka TA; Heliö T; Salonen JT
Circulation; 1999 Sep; 100(12):1274-9. PubMed ID: 10491370
[TBL] [Abstract][Full Text] [Related]
11. [From gene to disease; HFE-mutations in primary haemochromatosis].
Swinkels DW; Jacobs EM
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):652-6. PubMed ID: 12712648
[TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis.
Barton JC; Shih WW; Sawada-Hirai R; Acton RT; Harmon L; Rivers C; Rothenberg BE
Blood Cells Mol Dis; 1997; 23(1):135-45; discussion 145a-b. PubMed ID: 9215758
[TBL] [Abstract][Full Text] [Related]
13. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population--implications for haemochromatosis.
Murphy S; Curran MD; McDougall N; Callender ME; O'Brien CJ; Middleton D
Tissue Antigens; 1998 Nov; 52(5):484-8. PubMed ID: 9864039
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans.
Monaghan KG; Rybicki BA; Shurafa M; Feldman GL
Am J Hematol; 1998 Jul; 58(3):213-7. PubMed ID: 9662273
[TBL] [Abstract][Full Text] [Related]
15. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
[TBL] [Abstract][Full Text] [Related]
16. HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosis.
Gottschalk R; Seidl C; Löffler T; Seifried E; Hoelzer D; Kaltwasser JP
Tissue Antigens; 1998 Mar; 51(3):270-5. PubMed ID: 9550327
[TBL] [Abstract][Full Text] [Related]
17. Genetics of hemochromatosis.
Cullen LM; Anderson GJ; Ramm GA; Jazwinska EC; Powell LW
Annu Rev Med; 1999; 50():87-98. PubMed ID: 10073265
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancer.
Robinson JP; Johnson VL; Rogers PA; Houlston RS; Maher ER; Bishop DT; Evans DG; Thomas HJ; Tomlinson IP; Silver AR
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1460-3. PubMed ID: 15941956
[TBL] [Abstract][Full Text] [Related]
19. Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis.
Rhodes DA; Raha-Chowdhury R; Cox TM; Trowsdale J
J Med Genet; 1997 Sep; 34(9):761-4. PubMed ID: 9321765
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
Bonkovsky HL; Jawaid Q; Tortorelli K; LeClair P; Cobb J; Lambrecht RW; Banner BF
J Hepatol; 1999 Sep; 31(3):421-9. PubMed ID: 10488699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
